Primary Amyloidosis — Trials

Primary Amyloidosis — Trials · CancerIndex

Clinical trials

Registered studies

106 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01728259	First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD	terminated	Phase 1	18	Barbara Ann Karmanos Cancer InstituteOTHER	2	May 9, 2023	clinicaltrials
NCT04115956	A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) Amyloidosis	terminated	Phase 1	6	Oncopeptides ABINDUSTRY	9	Mar 28, 2022	clinicaltrials